Diagnostics

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)

Featured article strengthens growing body of clinical evidence for Nociscan by highlighting a successful case studySpecial Pain issue features breakthrough…

1 day ago

Plus Therapeutics Highlights Three REYOBIQ™ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting

Cohort 1 data from multiple dose ReSPECT- Leptomeningeal Metastases (LM) trial showed no dosage limiting toxicity ReSPECT-Glioblastoma (GBM) trial of…

1 day ago

Monod Bio and Gator Bio Partner to Develop Next-Generation Biosensors for Advanced Life Science Research

Gator will integrate one of Monod's AI-designed NovoBody™ binding proteins into its industry-leading biolayer interferometry platformNovoBody™ binding proteins deliver superior…

2 days ago

Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion

NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a…

2 days ago

New Horizon Medical Solutions Announces Exclusive US Partnership with Kent Imaging

New Horizon Medical Solutions is building a new future in wound care by combining advanced diagnostics with a comprehensive product…

2 days ago

Bioz Stars Awards 2025: Honoring Global Leaders Driving the Future of Scientific Innovation

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 3, 2025 / Bioz, Inc., the world's leading AI-powered platform for scientific…

2 days ago

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

FDA scientific advice meeting provides guidance on planned Phase 3 study of radiodiagnostic lead candidate in treatment-resistant hypertension / primary…

2 days ago

DiagnosTear Announces Clinical Study with AlyaTec to Advance Analytical Validation and FDA Submission Pathway of TeaRx(TM) Red Eye Diagnostic Test

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"),…

3 days ago